Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) have been given a consensus rating of “Moderate Buy” by the eight research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $91.22.

Several equities analysts recently commented on ACHC shares. Mizuho increased their target price on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, March 6th. Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price on the stock in a research report on Friday, January 5th. TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. TD Cowen raised their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th.

View Our Latest Analysis on ACHC

Acadia Healthcare Trading Down 0.4 %

Shares of NASDAQ ACHC opened at $75.74 on Wednesday. The stock has a market capitalization of $6.99 billion, a PE ratio of -302.95, a PEG ratio of 2.34 and a beta of 1.31. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock has a fifty day simple moving average of $81.33 and a 200-day simple moving average of $77.32. Acadia Healthcare has a twelve month low of $66.49 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. During the same quarter in the prior year, the company earned $0.70 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. On average, equities analysts forecast that Acadia Healthcare will post 3.57 earnings per share for the current year.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.80% of the company’s stock.

Institutional Trading of Acadia Healthcare

Institutional investors have recently modified their holdings of the business. Fifth Third Bancorp lifted its position in shares of Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the period. Estate Counselors LLC raised its holdings in Acadia Healthcare by 0.9% during the third quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock worth $1,154,000 after purchasing an additional 145 shares during the last quarter. Verition Fund Management LLC boosted its position in Acadia Healthcare by 4.5% during the fourth quarter. Verition Fund Management LLC now owns 3,601 shares of the company’s stock worth $296,000 after purchasing an additional 155 shares in the last quarter. Tranquility Partners LLC grew its holdings in Acadia Healthcare by 5.3% in the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock valued at $264,000 after purchasing an additional 170 shares during the last quarter. Finally, Truist Financial Corp increased its position in shares of Acadia Healthcare by 0.3% in the fourth quarter. Truist Financial Corp now owns 49,387 shares of the company’s stock valued at $4,066,000 after buying an additional 171 shares in the last quarter.

Acadia Healthcare Company Profile

(Get Free Report

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.